Türkdoğan, D. Et Al. 2019. Ketogenic diet as a successful early treatment modality for SCN2A mutation. BRAIN & DEVELOPMENT , vol.41 , 389-391.

Türkdoğan, D., Thomas, G., & Demirel, B., (2019). Ketogenic diet as a successful early treatment modality for SCN2A mutation. BRAIN & DEVELOPMENT , vol.41, 389-391.

Türkdoğan, DİLŞAD, Gulten Thomas, And Birsen Demirel. "Ketogenic diet as a successful early treatment modality for SCN2A mutation," BRAIN & DEVELOPMENT , vol.41, 389-391, 2019

Türkdoğan, DİLŞAD Et Al. "Ketogenic diet as a successful early treatment modality for SCN2A mutation." BRAIN & DEVELOPMENT , vol.41, pp.389-391, 2019

Türkdoğan, D. Thomas, G. And Demirel, B. (2019) . "Ketogenic diet as a successful early treatment modality for SCN2A mutation." BRAIN & DEVELOPMENT , vol.41, pp.389-391.

@article{article, author={DİLŞAD TÜRKDOĞAN Et Al. }, title={Ketogenic diet as a successful early treatment modality for SCN2A mutation}, journal={BRAIN & DEVELOPMENT}, year=2019, pages={389-391} }